We have located links that may give you full text access.
English Abstract
Journal Article
[2018 new recommendations for dyslipidemia : a critical review of evidence].
Revue Médicale Suisse 2018 Februrary 29
Dyslipidemia is an important cardiovascular risk factor. Its management should be individualized according to cardiovascular risk, which can be estimated using PROCAM score, taking into account patients' comorbidities. Cardiovascular risk is classified as low, moderated or high. The Swiss Atherosclerosis Association (AGLA) recently published new recommendations that we are describing taking into account evidence of recent studies, in order to avoid overmedicalisation. Lifestyle interventions should always be implemented and are the main therapy for most patients in primary prevention. A secondary etiology should be excluded, as its treatment can often normalize the lipid disturbance. Familial dyslipidemia should be looked for, as it is associated with a particularly high cardiovascular risk, and because of its specific management.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app